Thread replies: 7
Thread images: 1
Thread images: 1
File: mark-2-darker.png (50KB, 476x475px) Image search:
[Google]
50KB, 476x475px
"Drug Supply Chain Security Act (DSCSA), outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States"
https://www.fda.gov/Drugs/DrugSafety/DrugIntegrityandSupplyChainSecurity/DrugSupplyChainSecurityAct/
BlockRx claims to solve this problem cost efficiently and have gained interest and connections in pharma industry.
Has anybody studied this further? Sounds promising
>>
>>3448760
Does it have any competition?
>>
>>3448876
Modum.io sounds like a competitor
>>
>>3448938
thanks for pointing them out. Although I think there would be space for both of them, especially with Blockrx's pharma connections
>>
>>
>>3448760
>Pharma want to turn off the tap on their secondary markets and lose ~15% of revenues
They would only do it if it meant relaxing how simply one could get access to the drugs. They aren't pumping out new versions of synthetic opioids while campaigning against medicinal MJ FDA trials for patient safety.
>>
>>3449087
I'm not following, what secondary market?
Thread posts: 7
Thread images: 1
Thread images: 1